CN108096409A - It is a kind of（Quickly）The drug and manufacturing method of scar are stayed in anti-inflammatory myogenic prevention - Google Patents
It is a kind of（Quickly）The drug and manufacturing method of scar are stayed in anti-inflammatory myogenic prevention Download PDFInfo
- Publication number
- CN108096409A CN108096409A CN201611034589.2A CN201611034589A CN108096409A CN 108096409 A CN108096409 A CN 108096409A CN 201611034589 A CN201611034589 A CN 201611034589A CN 108096409 A CN108096409 A CN 108096409A
- Authority
- CN
- China
- Prior art keywords
- parts
- scar
- prevention
- stayed
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 229940079593 drug Drugs 0.000 title claims abstract description 29
- 231100000241 scar Toxicity 0.000 title claims abstract description 28
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 25
- 230000002265 prevention Effects 0.000 title claims abstract description 24
- 230000001114 myogenic effect Effects 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000208340 Araliaceae Species 0.000 claims abstract description 14
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 14
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 14
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 14
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 14
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 14
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 14
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 14
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 14
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 14
- 239000004863 Frankincense Substances 0.000 claims abstract description 14
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 240000004980 Rheum officinale Species 0.000 claims abstract description 14
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 14
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 14
- 229940116229 borneol Drugs 0.000 claims abstract description 14
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000009136 dragon's blood Substances 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 229940099259 vaseline Drugs 0.000 claims abstract description 14
- 206010004542 Bezoar Diseases 0.000 claims abstract description 13
- 239000008159 sesame oil Substances 0.000 claims abstract description 12
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 12
- 239000004166 Lanolin Substances 0.000 claims abstract description 11
- 229940039717 lanolin Drugs 0.000 claims abstract description 11
- 235000019388 lanolin Nutrition 0.000 claims abstract description 11
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 claims abstract description 8
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 239000011248 coating agent Substances 0.000 claims abstract description 4
- 238000000576 coating method Methods 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims abstract description 4
- 238000004321 preservation Methods 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 3
- 239000002689 soil Substances 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 10
- 239000000835 fiber Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- 210000002268 wool Anatomy 0.000 claims 2
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 claims 1
- 241001416180 Moschidae Species 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 210000004209 hair Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 206010052428 Wound Diseases 0.000 description 15
- 230000035876 healing Effects 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 208000004210 Pressure Ulcer Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 201000006994 chronic ulcer of skin Diseases 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses the drugs and manufacturing method that scar is stayed in a kind of (quick) anti-inflammatory myogenic prevention, belong to drug pharmaceutical technology field, are made of following raw material drug：2~3 parts of lanolin, 1~2 part of sesame oil, Huang are dwelt 12 parts; 12 parts of the coptis, 1 part of ginseng, 2 parts of borneol; 4~9 parts of myrrh, 3~10 parts of Huang Qin, 2~5 parts of pearl; 1~6 part of muscone, 3~6 parts of safflower, 3~10 parts of frankincense; 3~10 parts of dragon's blood; 1~6 part of cow-bezoar, 3~10 parts of rheum officinale, 8~10 parts of vaseline base.Including following manufacturing step：Step 1, extraction ginseng, it is yellow dwell, the coptis, myrrh, Huang Qin, frankincense, safflower, the elite of rheum officinale；Cow-bezoar, dragon's blood, borneol, pearl are mixed and are finely ground into powder by step 2；Step 3, each elite extracted in step 1 is mixed with sesame oil heat preservation 1 it is small when after stirred evenly with the mixed soil obtained by step 2；Step 4 adds in lanolin in mixture obtained by step 3 under room temperature and vaseline base stirs evenly and obtains wound coating medication.Curative effect of medication is good.
Description
Technical field
The present invention relates to postoperative prevention wound infection medicine field, scar is stayed in more particularly to a kind of (quick) anti-inflammatory myogenic prevention
Drug and manufacturing method.
Background technology
The edge of a knife after surgery and the healing stage that all kinds of weight degree wounds generally require certain time is injured outside, cure at present
Educational circles is mainly the therapy by (sterile debridement and antibiotic are anti-inflammatory), mostly using antibiotic and sulfa drug, this side
Method is only suitable for small wound, and easily stays scar to the well damage of skin, is not suitable for using, now mostly using medicine for external application, but often
There is no the effect of anti-inflammatory analgetic, and it is poor for applicability with the antiphlogistic antibacterial of Western medicine, it be easy to cause wound surface healing inside and still sends out
The phenomenon that scorching, causes the wound obstinate of patient, is more easy to the scar left.
The content of the invention
In view of the deficiencies of the prior art, the present invention provides the drug and system that scar is stayed in a kind of a kind of (quick) anti-inflammatory myogenic prevention
Make method.
To achieve these goals, the technical solution adopted by the present invention to solve the technical problems is：It is a kind of (quick) anti-
The drug of scar is stayed in scorching myogenic prevention, is made of following raw material drug：2~3 parts of lanolin, 1~2 part of sesame oil, yellow Kashiwa 1-2
Part, 1-2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 4~9 parts of myrrh, 3~10 parts of Huang Qin, 3~10 parts of pearl, muscone 1~6
Part, 3~6 parts of safflower, 3~10 parts of frankincense, 3~10 parts of dragon's blood, 1~6 part of cow-bezoar, 3~10 parts of rheum officinale, vaseline base 8~
10 parts.
The present invention further provides the prevention of one kind (quick) anti-inflammatory myogenic stay the drug of scar, 2~3 parts of lanolin, fiber crops
1.5~2 parts of oil, yellow Kashiwa 1.5-2 parts, 1.5-2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 6~9 parts of myrrh, 5~10 parts of Huang Qin, treasure
5~10 parts of pearl, 3~6 parts of muscone, 4~6 parts of safflower, 4~10 parts of frankincense, 5~10 parts of dragon's blood, 3~6 parts of cow-bezoar, rheum officinale
5~10 parts, 9~10 parts of vaseline base.
The present invention further provides the prevention of one kind (quick) anti-inflammatory myogenic stay the drug of scar, 2 parts of lanolin, sesame oil 2
Part, yellow 2 parts of Kashiwa, 2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 8 parts of myrrh, 8 parts of Huang Qin, 4 parts of pearl, 3 parts of muscone, safflower
3 parts, 8 parts of frankincense, 8 parts of dragon's blood, 5 parts of cow-bezoar, 8 parts of rheum officinale, 8 parts of vaseline base.
The manufacture method of medicine of scar is stayed in a kind of (quick) anti-inflammatory myogenic prevention, comprises the following steps：Step 1 extracts people
Ginseng, yellow Kashiwa, the coptis, myrrh, Huang Qin, frankincense, safflower, the juice of rheum officinale；Step 2 mixes cow-bezoar, dragon's blood, borneol, pearl
Conjunction is finely ground into powder；Step 3, each elite extracted in step 1 is mixed with sesame oil heat preservation 1 it is small when after with step 2 obtained by
Mixed soil stir evenly；Step 4 adds in lanolin and the stirring of vaseline base under room temperature in mixture obtained by step 3
Uniformly obtain wound coating medication.
The present invention further provides the prevention of one kind (quick) anti-inflammatory myogenic stay the manufacture method of medicine of scar, in step 3
Holding temperature be 40~50 degrees Celsius.
The present invention further provides the prevention of one kind (quick) anti-inflammatory myogenic stay the manufacture method of medicine of scar, in step 4
The room temperature is 22~28 degrees Celsius.
Drug external application drug effect of the present invention is with strong points, subtracts antibiotic, rapid healing wound, and scar is stayed in prevention
Sterilization, anti-inflammatory, detumescence, analgesic, putrefaction-removing granulation-promoting prevent local infection, eliminate suture reaction, moisten wound granulation group
The effect of knitting fast-growth, accelerating Wound healing, and effectively early prevention scar is formed；Using advanced low-temperature extraction skill
Active highest ingredient in raw material is extracted, utmostly ensure that the work of herbal raw material by art and its breaking-wall cell processing
Property, effect promoting several times.
Specific embodiment
A kind of a kind of (quick) anti-inflammatory myogenic as described in claim 1 prevents to stay the manufacture method of medicine of scar, including with
Lower step：Step 1, extraction ginseng, yellow Kashiwa, the coptis, myrrh, Huang Qin, frankincense, safflower, the elite of rheum officinale；Step 2, by ox
Huang, dragon's blood, borneol, pearl mixing fine gtinding；It is small to be mixed with sesame oil heat preservation 1 by step 3 for each juice extracted in step 1
Mixture obtained by Shi Houyu step 2 stirs evenly；Step 4 adds in lanolin under room temperature in mixture obtained by step 3
It is stirred evenly with vaseline base and obtains wound coating medication.
Holding temperature in the step 3 is 40~50 degrees Celsius.
Room temperature described in the step 4 is 22~28 degrees Celsius.
Embodiment one
The drug of scar is stayed in a kind of (quick) anti-inflammatory myogenic prevention, is made of following raw material drug：Lanolin 2~3
Part, 2~3 parts of sesame oil, yellow Kashiwa 1-2 parts, 1-2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 4~9 parts of myrrh, 3~10 parts of Huang Qin, pearl
3~10 parts, 2~6 parts of muscone, 3~6 parts of safflower, 3~10 parts of frankincense, 3~10 parts of dragon's blood, 1~6 part of cow-bezoar, rheum officinale 3
~10 parts, 8~10 parts of vaseline base.
Embodiment two
The drug of scar, 2~3 parts of the lanolin, 1.5~3 parts of sesame oil, yellow Kashiwa are stayed in a kind of (quick) anti-inflammatory myogenic prevention
1.5~2 parts, 1.5~2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 6~9 parts of myrrh, 5~10 parts of Huang Qin, 5~10 parts of pearl, manually
1~6 part of Moschus, 4~6 parts of safflower, 4~10 parts of frankincense, 5~10 parts of dragon's blood, 3~6 parts of cow-bezoar, 5~10 parts of rheum officinale, vaseline
8~10 parts of base.
The drug of scar, 2 parts of the lanolin, 1 part of sesame oil, yellow 2 parts of Kashiwa, the coptis 2 are stayed in a kind of (quick) anti-inflammatory myogenic prevention
Part, 1 part of ginseng, 2 parts of borneol, 8 parts of myrrh, 8 parts of Huang Qin, 4 parts of pearl, 3 parts of muscone, 4 parts of safflower, 8 parts of frankincense, dragon's blood
8 parts, 3 parts of cow-bezoar, 8 parts of rheum officinale, 8 parts of vaseline base.
Using after the drug of the various embodiments described above component and dosage, to all kinds of wounds, burn and scald, operation wound, bedsore, always
The hardly possible healing wounds such as rotten leg, diabetes, frostbite have sterilization, anti-inflammatory, detumescence, analgesic, putrefaction-removing granulation-promoting, promote granulation tissue quick
Growth accelerates Wound healing effect.It can prevent local infection, eliminate suture reaction, prevention scar is formed.The drug has anti-inflammatory
Analgesic, putrefaction-removing granulation-promoting, healing acceleration prevent the function of scar, solve operation postoperative wound and recover that healing is slow, easy infection stays scar
Problem.
The drug externally-applied ointment being prepared using the method described in the application after testing, without hormone etc..It can control
Various new, old open skin traumas, such as incised injury, blunt force injury, accidental wound, scald, ulcer on the shank etc. are treated, doctor trained in Western medicine claims various hands
Art wound, accident trauma, infected wound, chronic ulcer of skin, pressure sore etc., and wound healing time is short.
Claims (6)
- The drug of scar is stayed in a kind of 1. (quick) anti-inflammatory myogenic prevention, which is characterized in that is made of following raw material drug：Sheep 2~3 parts of fat of hair, 1~2 part of sesame oil, yellow Kashiwa 1-2 parts, 1-2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 4~9 parts of myrrh, Huang Qin 3~ 10 parts, 2~5 parts of pearl, 1~6 part of muscone, 3~6 parts of safflower, 3~10 parts of frankincense, 3~10 parts of dragon's blood, cow-bezoar 1~6 Part, 3~10 parts of rheum officinale, 8~10 parts of vaseline base.
- 2. the drug of scar is stayed in the anti-inflammatory myogenic prevention of one kind (quick) according to claim 1, which is characterized in that the wool 2~3 parts of fat, 1.5~3 parts of sesame oil, yellow Kashiwa 1.5-2 parts, 1.5-2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 6~9 parts of myrrh, Huang Qin 5~10 parts, 2~5 parts of pearl, 2~6 parts of muscone, 4~6 parts of safflower, 4~10 parts of frankincense, 5~10 parts of dragon's blood, cow-bezoar 3 ~6 parts, 5~10 parts of rheum officinale, 9~10 parts of vaseline base.
- 3. the drug of scar is stayed in the anti-inflammatory myogenic prevention of one kind (quick) according to claim 1, which is characterized in that the wool 2 parts of fat, 2 parts of sesame oil, yellow 2 parts of Kashiwa, 2 parts of the coptis, 1 part of ginseng, 2 parts of borneol, 8 parts of myrrh, 8 parts of Huang Qin, 4 parts of pearl, artificial musk deer It is 3 parts fragrant, 3 parts of safflower, 8 parts of frankincense, 8 parts of dragon's blood, 5 parts of cow-bezoar, 8 parts of rheum officinale, 8 parts of vaseline base.
- 4. the manufacture method of medicine of scar is stayed in a kind of a kind of (quick) as described in claim 1 anti-inflammatory myogenic prevention, feature exists In comprising the following steps：Step 1, extraction ginseng, yellow Kashiwa, the coptis, myrrh, Huang Qin, frankincense, safflower, the elite of rheum officinale；Step Rapid two, cow-bezoar, dragon's blood, borneol, pearl are mixed and are finely ground into powder；Step 3, by each elite extracted in step 1 and fiber crops It is stirred evenly after when oil mixing heat preservation 1 is small with the mixed soil obtained by step 2；Step 4, in mixture obtained by step 3 under room temperature Middle addition lanolin and vaseline base, which stir evenly, obtains wound coating medication.
- 5. the manufacture method of medicine of scar is stayed in the anti-inflammatory myogenic prevention of one kind (quick) according to claim 4, which is characterized in that Holding temperature in step 3 is 40~50 degrees Celsius.
- 6. the manufacture method of medicine of scar is stayed in the anti-inflammatory myogenic prevention of one kind (quick) according to claim 4, which is characterized in that Room temperature described in step 4 is 22~28 degrees Celsius.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611034589.2A CN108096409A (en) | 2016-11-23 | 2016-11-23 | It is a kind of（Quickly）The drug and manufacturing method of scar are stayed in anti-inflammatory myogenic prevention |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611034589.2A CN108096409A (en) | 2016-11-23 | 2016-11-23 | It is a kind of（Quickly）The drug and manufacturing method of scar are stayed in anti-inflammatory myogenic prevention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108096409A true CN108096409A (en) | 2018-06-01 |
Family
ID=62203677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611034589.2A Pending CN108096409A (en) | 2016-11-23 | 2016-11-23 | It is a kind of（Quickly）The drug and manufacturing method of scar are stayed in anti-inflammatory myogenic prevention |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108096409A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110354061A (en) * | 2019-08-12 | 2019-10-22 | 山东佳硒雅生物有限公司 | A kind of selenium-rich is dispelled scar frost and preparation method thereof |
| CN112190650A (en) * | 2020-11-26 | 2021-01-08 | 董亚利 | Traditional Chinese medicine composition and medicament for treating skin wounds |
| CN113456738A (en) * | 2021-04-23 | 2021-10-01 | 刘天峰 | Burn, scald, sore and ulcer oil with pure traditional Chinese medicine formula and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257963A (en) * | 2014-09-13 | 2015-01-07 | 董亚利 | Medicine for preventing postoperative infection and scars |
| CN105748841A (en) * | 2016-04-01 | 2016-07-13 | 郑州密丽药业有限公司 | Medicine for treating burns and scalds and preventing healed scar formation and preparation method thereof |
-
2016
- 2016-11-23 CN CN201611034589.2A patent/CN108096409A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104257963A (en) * | 2014-09-13 | 2015-01-07 | 董亚利 | Medicine for preventing postoperative infection and scars |
| CN105748841A (en) * | 2016-04-01 | 2016-07-13 | 郑州密丽药业有限公司 | Medicine for treating burns and scalds and preventing healed scar formation and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110354061A (en) * | 2019-08-12 | 2019-10-22 | 山东佳硒雅生物有限公司 | A kind of selenium-rich is dispelled scar frost and preparation method thereof |
| CN112190650A (en) * | 2020-11-26 | 2021-01-08 | 董亚利 | Traditional Chinese medicine composition and medicament for treating skin wounds |
| CN113456738A (en) * | 2021-04-23 | 2021-10-01 | 刘天峰 | Burn, scald, sore and ulcer oil with pure traditional Chinese medicine formula and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108096409A (en) | It is a kind of（Quickly）The drug and manufacturing method of scar are stayed in anti-inflammatory myogenic prevention | |
| CN105311332A (en) | Ulcer stopping and tissue regeneration promoting powder | |
| CN107184761A (en) | A kind of pharmaceutical composition of warming and activating meridian analgesic and its production and use | |
| CN104306402B (en) | A kind of Chinese medicine composition for treating burn and scald infection and preparation method thereof | |
| CN105031622A (en) | Pharmaceutical composition capable of promoting wound healing, and preparation method thereof | |
| WO2002100385A1 (en) | Crude drug patch | |
| CN106880765B (en) | A powder that promotes wound healing | |
| Shaikh et al. | Traditional remedies for wound healing: a review | |
| CN110624008A (en) | Rheumatic pain therapeutic belt | |
| CN109432117B (en) | A kind of external medicine for promoting postoperative skin wound healing and use thereof | |
| CN104257719B (en) | Chinese and Western medicine multipurpose ointment of dispersing swelling and dissipating binds and preparation method thereof | |
| CN107596132A (en) | It is a kind of to be used to treat burn, pharmaceutical composition of scald and its preparation method and application | |
| RU2582294C1 (en) | Patch with pepper extract | |
| CN101837084A (en) | Externally-used medicinal composite preparation for treating alopecia and manufacturing method thereof | |
| CN111419952B (en) | Traditional Chinese medicine composition with hemostatic and analgesic effects and preparation method and application thereof | |
| KR101607229B1 (en) | A composition for treating wound containing horse oil | |
| CN101085092A (en) | Ointment for treating and healing wound | |
| CN104107236B (en) | A kind of orthopaedics ointment treating fracture, muscle and tendon injury and preparation method thereof | |
| KR20100117864A (en) | Pharmaceutical composition for burn treatment | |
| CN105748686A (en) | Medicine for treating burn and scald and preparation method of medicine | |
| CN1176710C (en) | Medicine for treating burn and scald and preparation method thereof | |
| CN119303019A (en) | Drug composition, preparation and preparation method of thin gauze for burn wounds capable of detoxification and astringency | |
| CN107050233A (en) | A kind of Chinese medicine paste formulation and preparation method for treating diabetes skin damaged | |
| CN104490923A (en) | Healing paste | |
| CN104188898A (en) | External preparation containing mangiferin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180601 |
|
| RJ01 | Rejection of invention patent application after publication |